
  
    
      
        Background_NNP
        
          BLM_NNP is_VBZ a_DT member_NN of_IN the_DT RecQ_NNP family_NN of_IN DNA_NNP
          helicases_NNS
          Bloom_NNP syndrome_NN (_( BS_NNP )_) is_VBZ a_DT rare_JJ cancer-prone_JJ autosomal_NN
          recessive_JJ disorder_NN characterized_VBN by_IN genomic_JJ instability_NN ,_,
          immunodeficiency_NN ,_, infertility_NN and_CC small_JJ stature_NN [_NN 1_CD ,_, 2_CD ]_NN ._.
          BS_NNP cells_NNS have_VBP a_DT distinctive_JJ genomic_JJ instability_NN :_: a_DT high_JJ
          frequency_NN of_IN sister_NN chromatid_NN exchange_NN (_( SCEs_NNP )_) and_CC
          quadriradial_NN formation_NN ._. 
          BLM_NNP ,_, the_DT gene_NN mutated_VBN in_IN BS_NNP ,_,
          encodes_NNS a_DT DNA_NNP helicase_NN (_( BLM_NNP )_) of_IN the_DT RecQ_NNP family_NN [_NN 3_CD ]_NN ._. BLM_NNP
          shares_VBZ the_DT most_JJS identity_NN in_IN the_DT helicase_NN domain_NN to_TO the_DT
          mouse_NN and_CC Xenopus_NNP orthologs_NNS [_NN 4_CD ,_, 5_CD ,_, 6_CD ]_NN ,_, to_TO a_DT predicted_VBD 
          C_NNP ._. elegans_NNS protein_NN CAB_NNP 05609_CD [_NN 7_CD ]_NN ,_,
          and_CC to_TO 
          D_NNP ._. melanogaster_NN dmBLM_NN [_NN 8_CD ]_NN ._. BLM_NNP can_MD
          partially_RB complement_VB phenotypes_NNS of_IN mutations_NNS in_IN the_DT 
          S_NNP ._. cerevisiae_NN SGS_NNP 1_CD gene_NN [_NN 9_CD ,_, 10_CD ]_NN ._.
          There_EX are_VBP two_CD published_VBN reports_NNS of_IN 
          BLM_NNP knock-out_JJ mice_NNS :_: one_CD strategy_NN
          used_VBD a_DT single_JJ deletion_NN allele_NN and_CC found_VBD that_IN the_DT
          homozygous_JJ null_NN mutants_NNS are_VBP embryonic_JJ lethals_NNS [_NN 4_CD ]_NN ;_: the_DT
          second_JJ strategy_NN used_VBD two_CD different_JJ deletion_NN alleles_NNS and_CC
          recovered_VBD full_RB sized_VBD ,_, fertile_JJ compound_NN heterozygote_NN mice_NNS
          with_IN an_DT elevated_VBD incidence_NN of_IN cancer_NN [_NN 5_CD ]_NN ._. The_DT second_JJ
          mouse_NN model_NN was_VBD made_VBN with_IN ES_NNP cells_NNS that_WDT have_VBP a_DT high_JJ
          frequency_NN of_IN SCEs_NNP before_IN injection_NN and_CC recapitulates_NNS the_DT
          BS_NNP phenotypes_NNS more_RBR accurately_RB ._.
          There_EX are_VBP four_CD other_JJ human_JJ genes_NNS in_IN the_DT RecQ_NNP family_NN :_: 
          RecQL_NNP /_NN RecQl_NNP ,_, WRN_NNP ,_, RecQ_NNP 4_CD ,_, RecQ_NNP 5_CD [_NN
          11_CD ,_, 12_CD ]_NN ._. 
          WRN_NNP is_VBZ the_DT gene_NN mutated_VBN in_IN Werner_NNP
          syndrome_NN ,_, a_DT premature_JJ aging_NN disorder_NN ;_: WS_NNP cells_NNS also_RB show_VBP
          features_NNS of_IN genomic_JJ instability_NN [_NN 13_CD ]_NN ._. WRN_NNP encodes_NNS an_DT
          exonuclease_NN activity_NN and_CC shares_NNS many_JJ similar_JJ in_IN vitro_NN
          helicase_NN activities_NNS with_IN BLM_NNP [_NN 14_CD ,_, 15_CD ]_NN ._. Mutations_NNP in_IN the_DT 
          RECQ_NNP 4_CD gene_NN have_VBP been_VBN found_VBN in_IN
          persons_NNS with_IN Rothmund-_NNP Thomson_NNP syndrome_NN ,_, a_DT rare_JJ premature_JJ
          aging_NN and_CC cancer-prone_JJ disorder_NN [_NN 16_CD ]_NN ._. Previous_JJ work_NN from_IN
          this_DT laboratory_NN and_CC others_NNS [_NN 10_CD ,_, 17_CD ,_, 18_CD ,_, 19_CD ]_NN demonstrated_VBD
          the_DT DNA_NNP helicase_NN activity_NN of_IN BLM_NNP in_IN vitro_NN on_IN a_DT variety_NN of_IN
          DNA_NNP substrates_NNS ._. Transfection_NNP of_IN the_DT normal_JJ BLM_NNP cDNA_NN (_( but_CC
          not_RB missense_NN alleles_NNS lacking_VBG helicase_NN activity_NN )_) into_IN BS_NNP
          cells_NNS reduces_VBZ the_DT frequency_NN of_IN SCEs_NNP [_NN 10_CD ]_NN ,_, indicating_VBG
          that_IN the_DT DNA_NNP helicase_NN activity_NN of_IN BLM_NNP is_VBZ essential_JJ for_IN
          genomic_JJ stability_NN ._.
        
        
          BLM_NNP is_VBZ localized_VBN in_IN nuclear_JJ bodies_NNS and_CC the_DT
          nucleolus_JJ
          The_DT BLM_NNP DNA_NNP helicase_NN is_VBZ found_VBN in_IN two_CD distinct_JJ nuclear_JJ
          structures_NNS in_IN normal_JJ human_JJ cells_NNS ,_, ND_NNP 10_CD or_CC PML_NNP nuclear_JJ
          bodies_NNS (_( NBs_NNP )_) and_CC the_DT nucleolus_JJ [_NN 20_CD ]_NN ._. The_DT NBs_NNP are_VBP dynamic_JJ
          PML-dependent_NNP depots_NNS of_IN multiple_JJ proteins_NNS disrupted_VBN upon_IN
          viral_JJ infection_NN and_CC in_IN certain_JJ human_JJ malignancies_NNS [_NN 21_CD ,_,
          22_CD ,_, 23_CD ]_NN ._. BS_NNP cells_NNS have_VBP NBs_NNP of_IN normal_JJ morphology_NN [_NN 21_CD ,_,
          22_CD ]_NN ,_, and_CC cells_NNS lacking_VBG PML_NNP destabilize_VB the_DT NBs_NNP and_CC have_VBP a_DT
          two_CD fold_VB increase_NN in_IN the_DT frequency_NN of_IN SCEs_NNP [_NN 22_CD ]_NN ._. NBs_NNP
          have_VBP been_VBN implicated_VBN in_IN the_DT regulation_NN of_IN apoptosis_NNS [_NN 21_CD ,_,
          24_CD ,_, 25_CD ]_NN although_IN their_PRP$ precise_JJ function_NN is_VBZ still_RB unknown_JJ ._.
          BLM_NNP expression_NN is_VBZ cell-cycle_JJ regulated_VBN ,_, showing_VBG a_DT marked_VBN
          increase_NN in_IN S_NNP phase_NN and_CC peaking_VBG in_IN G_NNP 2_CD [_NN 26_CD ,_, 27_CD ]_NN ._. The_DT
          increase_NN in_IN BLM_NNP mRNA_NN and_CC protein_NN expression_NN coincides_VBZ
          with_IN its_PRP$ appearance_NN in_IN the_DT nucleolus_JJ [_NN 20_CD ]_NN ._. This_DT report_NN
          uses_VBZ a_DT series_NN of_IN inducible_JJ cell_NN lines_NNS containing_VBG deletion_NN
          alleles_NNS of_IN BLM_NNP to_TO investigate_VB the_DT role_NN of_IN the_DT N-_NNP terminal_NN
          and_CC C-_NNP terminal_NN domains_NNS of_IN BLM_NNP in_IN nuclear_JJ localization_NN and_CC
          in_IN the_DT maintenance_NN of_IN genomic_JJ stability_NN ._. We_PRP find_VBP that_IN the_DT
          N-_NNP terminal_NN domain_NN directs_VBZ BLM_NNP for_IN packaging_NN in_IN NBs_NNP ,_, while_IN
          the_DT C-_NNP terminal_NN domain_NN is_VBZ required_VBN for_IN efficient_JJ nucleolar_NN
          localization_NN ._. Compared_VBN to_TO the_DT normal_JJ BLM_NNP protein_NN ,_,
          deletions_NNS of_IN the_DT C-_NNP terminus_JJ and_CC mutation_NN of_IN the_DT helicase_NN
          domain_NN have_VBP a_DT strong_JJ negative_JJ effect_NN on_IN genomic_JJ stability_NN
          whereas_IN deletions_NNS of_IN the_DT N-_NNP terminus_JJ have_VBP less_JJR effect_NN ._.
        
      
      
        Results_NNS
        
          GFP-BLM_NNP has_VBZ in_IN vitro_NN DNA_NNP helicase_NN activity_NN
          Epitope-tagged_NNP genes_NNS facilitate_VBP the_DT analysis_NN of_IN
          transfected_JJ cell_NN lines_NNS and_CC protein_NN recovery_NN ._. The_DT green_JJ
          fluorescent_NN protein_NN (_( GFP_NNP )_) is_VBZ especially_RB useful_JJ as_IN a_DT
          reporter_NN and_CC epitope_NN tag_NN due_JJ to_TO its_PRP$ ease_NN in_IN detection_NN and_CC
          apparent_JJ independent_JJ folding_NN that_WDT does_VBZ not_RB interfere_VB with_IN
          the_DT activity_NN of_IN its_PRP$ fusion_NN partner_NN [_NN 28_CD ]_NN ._. A_DT GFP-BLM_NNP
          expressing_VBG recombinant_JJ baculovirus_JJ was_VBD produced_VBN in_IN Sf_NNP 9_CD
          cells_NNS ._. Single_NNP virus_NN isolates_VBZ expressing_VBG GFP-BLM_NNP were_VBD
          identified_VBN using_VBG FACS_NNP and_CC PCR_NNP analysis_NN [_NN 29_CD ]_NN ._. Sf_NNP 9_CD cells_NNS
          infected_VBN with_IN the_DT purified_JJ primary_JJ stocks_NNS were_VBD screened_VBD
          by_IN immunofluorescent_NN microscopy_NN to_TO verify_VB accumulation_NN of_IN
          GFP-BLM_NNP in_IN the_DT nucleus_NN (_( Figure_NN 1_CD A_DT )_) ._. This_DT screening_NN
          verified_VBN full_JJ length_NN expression_NN as_IN GFP_NNP is_VBZ fused_JJ to_TO the_DT
          N-_NNP terminus_JJ of_IN BLM_NNP and_CC the_DT nuclear_JJ localization_NN signal_NN is_VBZ
          in_IN the_DT last_JJ 100_CD amino_JJ acids_NNS of_IN the_DT 1417_CD amino_JJ acid_NN BLM_NNP
          coding_VBG region_NN [_NN 30_CD ]_NN ._. GFP-BLM_NNP accumulates_NNS in_IN the_DT nucleus_NN
          of_IN infected_JJ Sf_NNP 9_CD cells_NNS as_IN large_JJ aggregates_NNS (_( Figure_NN 1_CD A_DT )_) ._.
          This_DT observation_NN is_VBZ consistent_JJ with_IN a_DT report_NN of_IN BLM_NNP
          oligomerization_NN [_NN 31_CD ]_NN ._. This_DT property_NN is_VBZ an_DT obstacle_NN to_TO
          purification_NN as_RB only_RB about_IN 10_CD %_NN of_IN the_DT expressed_VBN GFP-BLM_NNP
          is_VBZ soluble_JJ ._. GFP-BLM_NNP was_VBD purified_JJ using_VBG ion-exchange_JJ and_CC
          metal_NN chelate_NN resin_NN chromatography_NN (_( Figure_NN 1_CD B_NNP )_) ._. The_DT
          purified_JJ protein_NN has_VBZ DNA-dependent_NNP ATPase_NNP activity_NN and_CC
          DNA_NNP unwinding_VBG activity_NN (_( Figure_NN 1_CD C_NNP &_CC 1_CD D_NNP )_) equivalent_JJ to_TO
          previous_JJ preparations_NNS without_IN GFP_NNP expressed_VBD in_IN 
          S_NNP ._. cerevisiae_NN cells_NNS [_NN 10_CD ]_NN ._. GFP-BLM_NNP
          has_VBZ 5_CD units_NNS /_NN ng_NN unwinding_VBG activity_NN and_CC 10_CD units_NNS /_NN ng_NN
          DNA-dependent_NNP ATPase_NNP activity_NN as_IN compared_VBN to_TO 6_CD units_NNS /_NN ng_NN
          and_CC 7_CD units_NNS /_NN ng_NN for_IN BLM_NNP purified_JJ from_IN yeast_NN ._. These_DT data_NNS
          demonstrate_VBP that_IN GFP-BLM_NNP has_VBZ the_DT same_JJ enzymatic_JJ activity_NN
          as_IN normal_JJ BLM_NNP and_CC GFP-tagged_NNP variant_NN alleles_NNS can_MD be_VB used_VBN
          to_TO discover_VB the_DT functional_JJ domains_NNS of_IN BLM_NNP ._.
        
        
          Selection_NN and_CC analysis_NN of_IN transfected_JJ cell_NN lines_NNS
          expressing_VBG normal_JJ and_CC mutant_JJ BLM_NNP alleles_NNS under_IN
          doxycycline_NN control_NN
          An_DT SV_NNP 40_CD -_: transformed_VBN BS_NNP cell_NN line_NN (_( GM_NNP 0855_CD B_NNP )_) was_VBD
          transfected_JJ with_IN a_DT plasmid_NN containing_VBG an_DT expression_NN unit_NN
          for_IN the_DT tetracycline_NN or_CC doxycycline_NN (_( Tet_NNP )_) responsive_JJ
          transcriptional_NN transactivator_NN [_NN 32_CD ]_NN ._. Only_RB one_CD cell_NN line_NN
          (_( HG_NNP 2522_CD ._. 1_LS a_DT )_) out_IN of_IN 17_CD showed_VBD good_JJ responsiveness_NNS (_( 15_CD
          fold_VB )_) and_CC low_JJ uninduced_JJ background_NN expression_NN levels_NNS
          (_( 0_CD ._. 25_CD %_NN green_JJ cells_NNS )_) ._. A_DT series_NN of_IN deletion_NN alleles_NNS of_IN the_DT
          normal_JJ BLM_NNP cDNA_NN (_( B_NNP 3_LS )_) [_NN 3_CD ]_NN were_VBD constructed_VBN using_VBG
          restriction_NN sites_NNS and_CC oligonucleotide_NN adapters_NNS (_( Figure_NN
          2_LS )_) ._. These_DT genes_NNS were_VBD made_VBN as_IN in_IN frame_NN fusion_NN genes_NNS at_IN the_DT
          C-_NNP terminus_JJ of_IN EGFP_NNP and_CC cloned_VBN behind_IN the_DT Tet-responsive_NNP
          promoter_NN in_IN plasmid_NN pTRE_NN ._. HG_NNP 25221_CD a_DT cells_NNS were_VBD transfected_JJ
          with_IN the_DT normal_JJ and_CC mutant_JJ GFP-BLM_NNP genes_NNS and_CC stable_JJ
          hygromycin-resistant_JJ cell_NN lines_NNS were_VBD selected_VBN ._. Clones_NNP
          were_VBD picked_VBN and_CC screened_VBD for_IN nuclear_JJ localized_JJ green_JJ
          fluorescence_NN after_IN induction_NN ._. Cell_NNP lines_NNS expressing_VBG each_DT
          construction_NN were_VBD chosen_VBN for_IN further_JJ study_NN when_WRB the_DT
          background_NN level_NN of_IN green_JJ cells_NNS was_VBD less_JJR than_IN 10_CD %_NN and_CC the_DT
          percentage_NN of_IN green_JJ cells_NNS after_IN induction_NN was_VBD
          reproducibly_RB elevated_VBD (_( Table_NNP I_PRP )_) ._.
        
        
          GFP-BLM_NNP expression_NN can_MD be_VB regulated_VBN by_IN inducer_NN
          concentration_NN
          The_DT level_NN of_IN GFP-BLM_NNP produced_VBD with_IN increasing_VBG amounts_NNS
          of_IN Tet_NNP after_IN a_DT 24_CD hour_NN induction_NN period_NN was_VBD determined_VBN
          (_( Figure_NN 3_LS )_) ._. The_DT expression_NN of_IN GFP-BLM_NNP was_VBD calculated_VBN
          relative_JJ to_TO the_DT amount_NN of_IN BLM_NNP present_JJ in_IN a_DT normal_JJ
          SV_NNP 40_CD -_: transformed_VBN fibroblast_NN line_NN (_( GM_NNP 0637_CD B_NNP )_) ._. Tet_NNP
          concentrations_NNS from_IN 0_CD ._. 25_CD -_: 2_CD μg_NN /_NN ml_NN produced_VBD levels_NNS of_IN
          stable_JJ GFP-BLM_NNP expression_NN in_IN this_DT SV_NNP 40_CD -_: transformed_VBN BS_NNP
          cell_NN line_NN similar_JJ to_TO the_DT amount_NN found_VBD in_IN the_DT control_NN cell_NN
          line_NN ._. Based_VBN on_IN these_DT data_NNS 1_CD μg_NN /_NN ml_NN and_CC 24_CD hours_NNS were_VBD used_VBN
          as_IN the_DT standard_JJ induction_NN conditions_NNS to_TO evaluate_VB
          localization_NN and_CC SCE_NNP frequency_NN of_IN the_DT transfected_JJ cell_NN
          lines_NNS ._.
        
        
          Stable_NNP cell_NN lines_NNS containing_VBG the_DT mutant_JJ proteins_NNS
          are_VBP inducible_JJ with_IN Tet_NNP and_CC show_NN altered_VBD
          localization_NN
          The_DT cell_NN lines_NNS chosen_VBN for_IN study_NN contain_VBP some_DT
          constitutive_JJ expression_NN of_IN the_DT 
          BLM_NNP alleles_NNS but_CC show_VB good_JJ
          reproducible_JJ induction_NN (_( Table_NNP I_PRP )_) ._. The_DT localization_NN of_IN the_DT
          normal_JJ and_CC mutant_JJ GFP-BLM_NNP proteins_NNS was_VBD analyzed_VBN by_IN
          immunofluorescent_NN microscopy_NN (_( Figure_NN 4_LS )_) ._. Antibodies_NNP
          against_IN PML_NNP and_CC topoisomerase_NN IIIα_NNP [_NN 33_CD ]_NN were_VBD used_VBN as_IN
          marker_NN proteins_NNS for_IN the_DT NBs_NNP ._. A_DT human_JJ autoimmune_JJ serum_NN
          against_IN a_DT nucleolar_NN antigen_NN ANA-N_NNP was_VBD used_VBN for_IN nucleolar_NN
          co-localization_JJ (_( data_NNS not_RB shown_VBN )_) ._. The_DT cell_NN line_NN
          expressing_VBG GFP_NNP alone_RB showed_VBD diffuse_NN nuclear_JJ and_CC
          cytoplasmic_JJ green_JJ fluorescence_NN (_( Figure_NN 4_CD A_DT )_) ._. The_DT normal_JJ
          GFP-BLM_NNP fusion_NN protein_NN localizes_NNS to_TO NBs_NNP and_CC the_DT nucleolus_JJ
          (_( Figure_NN 4_CD B_NNP )_) as_RB previously_RB reported_VBD for_IN BLM_NNP in_IN normal_JJ
          human_JJ fibroblasts_NNS [_NN 20_CD ]_NN ._. The_DT fusion_NN protein_NN co-localizes_JJ
          with_IN PML_NNP and_CC TOPIIIα_NNP (_( Figure_NN 4_CD B_NNP &_CC 4_CD C_NNP )_) as_IN does_VBZ normal_JJ
          BLM_NNP [_NN 20_CD ,_, 21_CD ,_, 22_CD ,_, 33_CD ,_, 34_CD ]_NN ._. GFP-BLM_NNP is_VBZ distributed_VBN
          throughout_IN the_DT nucleolus_JJ except_IN for_IN several_JJ central_JJ
          regions_NNS that_WDT appear_VBP as_IN holes_NNS in_IN the_DT images_NNS ._. The_DT
          N-_NNP terminal_NN deletions_NNS of_IN BLM_NNP show_NN little_JJ NB_NNP localization_NN
          and_CC ΔN_NN 1_CD through_IN ΔN_NN 3_CD retain_VB the_DT nucleolar_NN localization_NN
          pattern_NN (_( Figure_NN 4_CD D_NNP ,_, E_NNP ,_, F_NN ,_, G_NNP )_) ._. The_DT ΔN_NN 4_CD fusion_NN protein_NN shows_VBZ
          mostly_RB diffuse_NN localization_NN but_CC nucleolar_NN localization_NN is_VBZ
          still_RB evident_JJ (_( Figure_NN 4_CD H_NNP )_) ._. In_IN 95_CD %_NN or_CC more_JJR of_IN the_DT cells_NNS in_IN
          the_DT induced_VBN populations_NNS there_RB is_VBZ little_RB co-localization_JJ
          with_IN PML_NNP or_CC TOPIIIα_NNP (_( Figures_NNS 4_CD D_NNP ,_, E_NNP ,_, F_NN ,_, G_NNP ,_, Table_NNP 1_LS )_) ._. These_DT
          results_NNS demonstrate_VBP that_IN the_DT normal_JJ GFP-BLM_NNP fusion_NN
          protein_NN restores_NNS the_DT BLM_NNP nuclear_JJ localization_NN pattern_NN to_TO
          this_DT BS_NNP cell_NN line_NN and_CC deletions_NNS of_IN the_DT N-_NNP terminus_JJ affect_NN
          the_DT packaging_NN of_IN BLM_NNP into_IN the_DT NBs_NNP ._.
        
        
          The_DT N_NNP 2_CD -_: N_NNP 4_CD regions_NNS of_IN BLM_NNP are_VBP required_VBN for_IN NB_NNP
          localization_NN
          By_IN visual_JJ inspection_NN each_DT induced_VBN cell_NN line_NN contains_VBZ
          cells_NNS expressing_VBG different_JJ levels_NNS of_IN the_DT fusion_NN proteins_NNS ._.
          The_DT ΔN_NN 1_CD expressing_VBG cells_NNS which_WDT exhibit_NN the_DT most_RBS intense_JJ
          green_JJ fluorescence_NN comprise_VBP 3_CD %_NN (_( 10_CD cells_NNS out_IN of_IN 300_CD
          counted_VBN )_) of_IN the_DT population_NN and_CC show_VB co-localization_JJ of_IN
          the_DT GFP_NNP signal_NN with_IN α-_NN PML_NNP and_CC α-_NN TopIIIa_NNP ._. This_DT small_JJ
          number_NN of_IN cells_NNS is_VBZ identical_JJ to_TO cells_NNS expressing_VBG normal_JJ
          GFP-BLM_NNP (_( Figure_NN 4_CD B_NNP &_CC 4_CD C_NNP )_) ._. The_DT cell_NN lines_NNS expressing_VBG
          ΔN_NN 2_CD ,_, ΔN_NN 3_CD and_CC ΔN_NN 4_CD do_VBP not_RB show_VB NB_NNP localization_NN (_( 0_CD out_IN of_IN
          300_CD cells_NNS )_) ._. Since_IN the_DT ΔN_NN 1_CD protein_NN shows_VBZ partial_JJ
          co-localization_JJ with_IN NBs_NNP the_DT N_NNP 1_CD region_NN is_VBZ not_RB absolutely_RB
          required_VBN for_IN BLM_NNP to_TO be_VB localized_JJ there_RB ._. The_DT other_JJ
          N-_NNP terminal_NN domains_NNS are_VBP required_VBN for_IN NB_NNP localization_NN ._.
        
        
          The_DT helicase_NN and_CC C-_NNP terminal_NN mutations_NNS of_IN BLM_NNP have_VBP
          very_RB different_JJ effects_NNS compared_VBN to_TO the_DT N-_NNP terminal_NN
          mutations_NNS
          The_DT two_CD GFP-fusion_NNP proteins_NNS with_IN mutations_NNS in_IN the_DT
          helicase_NN domain_NN have_VBP different_JJ localization_NN patterns_NNS ._. The_DT
          K_NNP 695_CD T_NN missense_NN protein_NN localizes_NNS to_TO NBs_NNP ,_, but_CC less_RBR
          efficiently_RB than_IN normal_JJ BLM_NNP ,_, and_CC to_TO the_DT nucleolus_JJ with_IN an_DT
          altered_VBN morphology_NN (_( Figure_NN 4_CD I_PRP )_) ._. The_DT K_NNP 695_CD T_NN fusion_NN protein_NN
          is_VBZ not_RB evenly_RB distributed_VBN throughout_IN the_DT outer_JJ nucleolar_NN
          region_NN but_CC shows_VBZ areas_NNS of_IN concentration_NN and_CC larger_JJR
          central_JJ holes_NNS ._. The_DT ΔH_NN 1_CD fusion_NN protein_NN has_VBZ a_DT diffuse_NN
          localization_NN pattern_NN throughout_IN the_DT nucleus_NN and_CC has_VBZ a_DT
          distinct_JJ altered_VBN nucleolar_NN localization_NN (_( Figure_NN 4_CD J_NNP )_) ._. This_DT
          fusion_NN protein_NN appears_VBZ in_IN the_DT central_JJ holes_NNS of_IN the_DT
          nucleolus_JJ where_WRB the_DT normal_JJ fusion_NN protein_NN is_VBZ not_RB found_VBN ._.
          Co-localization_NNP of_IN the_DT H_NNP 1_CD fusion_NN protein_NN and_CC α-_NN PML_NNP and_CC
          TOPHI_NNP 11_CD α_NN is_VBZ seen_VBN in_IN most_JJS cells_NNS ,_, and_CC fewer_JJR NBs_NNP are_VBP
          present_JJ ._. The_DT GFP-fusion_NNP proteins_NNS with_IN helicase_NN mutations_NNS
          are_VBP packaged_VBN into_IN the_DT NBs_NNP and_CC have_VBP altered_VBN nucleolar_NN
          localization_NN ._.
          The_DT two_CD GFP-fusion_NNP proteins_NNS with_IN C-_NNP terminal_NN mutations_NNS
          have_VBP different_JJ localization_NN patterns_NNS than_IN the_DT N-_NNP terminal_NN
          mutations_NNS ._. The_DT ΔC_NN 1_CD and_CC ΔC_NN 2_CD fusion_NN proteins_NNS co-localize_JJ
          efficiently_RB with_IN α-_NN PML_NNP and_CC α-_NN TOPIII_NNP (_( Figure_NN 4_CD K_NNP &_CC 4_CD L_NNP )_)
          and_CC have_VBP little_JJ nucleolar_NN localization_NN ._. In_IN addition_NN the_DT
          C-_NNP terminal_NN deletion_NN proteins_NNS form_VBP numerous_JJ small_JJ green_JJ
          nuclear_JJ bodies_NNS that_WDT do_VBP not_RB co-localize_JJ with_IN either_DT NB_NNP
          antibody_NN (_( BLM_NNP bodies_NNS ,_, BBs_NNP )_) ._. These_DT BBs_NNP are_VBP found_VBN in_IN cells_NNS
          expressing_VBG the_DT ΔN_NN 3_CD and_CC the_DT K_NNP 695_CD T_NN proteins_NNS (_( Figure_NN 4_CD H_NNP &_CC
          4_CD I_PRP )_) ._. The_DT BBs_NNP may_MD be_VB due_JJ to_TO formation_NN of_IN large_JJ oligomers_NNS
          or_CC aggregates_NNS of_IN less_RBR soluble_JJ fusion_NN proteins_NNS ._. The_DT
          significance_NN of_IN these_DT aggregates_NNS is_VBZ unknown_JJ ._. These_DT
          observations_NNS demonstrate_VBP that_IN the_DT N-_NNP terminal_NN domain_NN of_IN
          BLM_NNP is_VBZ required_VBN for_IN NB_NNP localization_NN and_CC the_DT C-_NNP terminal_NN
          domain_NN is_VBZ required_VBN for_IN accumulation_NN of_IN BLM_NNP in_IN the_DT
          nucleolus_JJ ._.
        
        
          The_DT mutant_JJ fusion_NN proteins_NNS are_VBP made_VBN as_IN stable_JJ
          full-length_JJ proteins_NNS
          The_DT differences_NNS in_IN localization_NN pattern_NN between_IN the_DT
          normal_JJ and_CC mutant_JJ alleles_NNS of_IN BLM_NNP is_VBZ not_RB due_JJ to_TO vastly_RB
          different_JJ levels_NNS of_IN stable_JJ fusion_NN protein_NN expression_NN ._.
          Western_JJ analysis_NN showed_VBD that_IN all_DT of_IN the_DT GFP_NNP fusion_NN genes_NNS
          are_VBP inducible_JJ and_CC are_VBP made_VBN as_IN full-length_JJ proteins_NNS
          (_( Figure_NN 5_LS )_) ._. The_DT N-_NNP terminal_NN deletion_NN fusion_NN proteins_NNS do_VBP
          not_RB fail_VB to_TO go_VB to_TO NBs_NNP because_IN of_IN reduced_VBN fusion_NN protein_NN
          expression_NN in_IN these_DT cell_NN lines_NNS ._. They_PRP are_VBP expressed_VBN as_IN
          stable_JJ full_JJ length_NN fusion_NN proteins_NNS at_IN levels_NNS close_RB to_TO
          those_DT of_IN the_DT normal_JJ GFP-BLM_NNP fusion_NN protein_NN (_( Table_NNP I_PRP ,_,
          Figure_NN 5_LS )_) ._. The_DT ΔN_NN 2_CD protein_NN is_VBZ relatively_RB over-expressed_JJ
          under_IN the_DT induction_NN conditions_NNS used_VBN ,_, while_IN the_DT ΔN_NN 3_CD and_CC
          ΔN_NN 4_CD proteins_NNS are_VBP expressed_VBN at_IN near_IN normal_JJ levels_NNS under_IN
          the_DT same_JJ induction_NN conditions_NNS ._. The_DT N-_NNP terminal_NN deletion_NN
          alleles_NNS have_VBP higher_JJR levels_NNS of_IN constitutive_JJ expression_NN
          relative_JJ to_TO the_DT C-_NNP terminal_NN mutations_NNS and_CC have_VBP overall_JJ
          higher_JJR levels_NNS of_IN protein_NN expression_NN ;_: one_CD explanation_NN is_VBZ
          that_IN the_DT C-_NNP terminal_NN mutations_NNS are_VBP deleterious_JJ ._.
        
        
          Most_JJS N-_NNP terminal_NN mutations_NNS have_VBP little_JJ effect_NN on_IN
          genomic_JJ stability_NN as_IN measured_VBN by_IN SCE_NNP frequency_NN
          BS_NNP cells_NNS have_VBP an_DT elevated_VBD frequency_NN of_IN SCEs_NNP [_NN 1_CD ]_NN ._. This_DT
          increase_NN in_IN homologous_RB recombination_NN leads_VBZ to_TO an_DT
          increased_VBN somatic_JJ mutation_NN frequency_NN and_CC genomic_JJ
          instability_NN ._. The_DT SCE_NNP frequency_NN was_VBD assayed_JJ in_IN the_DT
          inducible_JJ cell_NN lines_NNS (_( Figure_NN 6_CD ,_, Tables_NNP 2_CD &_CC 3_LS )_) ._. The_DT
          cell_NN line_NN expressing_VBG GFP_NNP alone_RB had_VBD a_DT nearly_RB identical_JJ
          frequency_NN of_IN SCEs_NNP with_IN and_CC without_IN induction_NN (_( 65_CD vs_NNS ._. 70_CD
          exchanges_NNS per_IN 46_CD chromosomes_NNS )_) ._. The_DT GFP-BLM_NNP cell_NN line_NN had_VBD
          an_DT elevated_VBD baseline_NN level_NN (_( 40_CD exchanges_NNS )_) but_CC showed_VBD
          significant_JJ reduction_NN upon_IN addition_NN of_IN inducer_NN (_( 40_CD to_TO 12_CD
          exchanges_NNS )_) ._. The_DT ΔN_NN 1_CD ,_, ΔN_NN 2_CD and_CC ΔN_NN 3_CD cell_NN lines_NNS showed_VBD less_JJR
          reduction_NN (_( 17_CD -_: 23_CD exchanges_NNS )_) and_CC slightly_RB higher_JJR baseline_NN
          levels_NNS (_( 47_CD -_: 58_CD exchanges_NNS )_) ._. These_DT cell_NN lines_NNS also_RB have_VBP a_DT
          distribution_NN of_IN SCEs_NNP slightly_RB elevated_VBD relative_JJ to_TO normal_JJ
          (_( Table_NNP 2_CD ,_, Figure_NN 6_CD A_DT )_) ._. The_DT ΔN_NN 4_CD cell_NN line_NN has_VBZ a_DT different_JJ
          distribution_NN and_CC shows_VBZ less_JJR correction_NN of_IN the_DT SCE_NNP
          frequency_NN (_( Table_NNP 2_CD ,_, Figure_NN 6_CD A_DT )_) ._. The_DT N-_NNP terminal_NN deletion_NN
          proteins_NNS show_VBP a_DT gradual_JJ increase_NN in_IN the_DT range_NN of_IN the_DT SCEs_NNP
          as_IN the_DT deletions_NNS approach_VBP the_DT helicase_NN domain_NN (_( Table_NNP
          2_LS )_) ._.
        
        
          The_DT helicase_NN and_CC C-_NNP terminal_NN mutations_NNS have_VBP a_DT
          destabilizing_JJ effect_NN
          The_DT helicase_NN and_CC C-_NNP terminal_NN mutations_NNS have_VBP a_DT greater_JJR
          effect_NN on_IN genomic_JJ stability_NN than_IN do_VBP the_DT N-_NNP terminal_NN
          mutations_NNS (_( Table_NNP 2_CD &_CC 3_CD ,_, Figure_NN 6_CD A_DT )_) ._. There_EX is_VBZ a_DT
          polarity_NN of_IN loss_NN of_IN function_NN seen_VBN across_IN the_DT gene_NN from_IN
          the_DT N-_NNP terminus_JJ to_TO the_DT C-_NNP terminus_JJ (_( Figure_NN 6_CD A_DT &_CC 6_CD B_NNP )_) ._.
          Most_JJS of_IN the_DT C-_NNP terminal_NN mutations_NNS appear_VBP to_TO have_VB a_DT
          dominant_JJ negative_JJ effect_NN ,_, as_IN the_DT frequency_NN of_IN SCEs_NNP is_VBZ
          higher_JJR with_IN Tet_NNP than_IN without_IN ._. The_DT most_RBS dramatic_JJ effects_NNS
          are_VBP seen_VBN in_IN the_DT ΔC_NN 1_CD and_CC to_TO a_DT lesser_JJR degree_NN in_IN the_DT ΔC_NN 2_CD
          induced_VBN cultures_NNS ,_, as_IN evidenced_VBN by_IN an_DT elevated_VBD frequency_NN
          of_IN ring_NN chromosomes_NNS [_NN 35_CD ]_NN (_( Table_NNP 3_CD ,_, Figure_NN 6_CD C_NNP )_) ._. This_DT may_MD
          indicate_VB breakage_NN and_CC rejoining_VBG events_NNS or_CC tangled_VBN
          telomeres_NNS ._. The_DT cell_NN line_NN containing_VBG the_DT helicase_NN
          deletion_NN ,_, ΔH_NN 1_CD ,_, has_VBZ an_DT elevated_VBD basal_NN frequency_NN of_IN SCEs_NNP
          and_CC a_DT higher_JJR chromosome_NN number_NN than_IN the_DT GFP_NNP control_NN cell_NN
          line_NN (_( Table_NNP 3_LS )_) yet_RB does_VBZ not_RB appear_VB to_TO be_VB as_RB deleterious_JJ
          as_IN the_DT K_NNP 695_CD T_NN and_CC C-_NNP terminal_NN deletions_NNS are_VBP when_WRB comparing_VBG
          relative_JJ SCE_NNP events_NNS ._. The_DT SCE_NNP analysis_NN of_IN this_DT cell_NN line_NN
          was_VBD complicated_VBN by_IN difficulty_NN in_IN finding_VBG chromosome_NN
          spreads_NNS and_CC by_IN the_DT small_JJ number_NN of_IN metaphases_NNS present_JJ in_IN
          the_DT cultures_NNS ._. Many_JJ of_IN the_DT metaphases_NNS could_MD not_RB be_VB
          counted_VBN ,_, as_IN the_DT chromosomes_NNS did_VBD not_RB separate_JJ under_IN the_DT
          optimized_JJ spreading_VBG conditions_NNS that_WDT worked_VBD efficiently_RB
          for_IN the_DT other_JJ cell_NN lines_NNS ._. The_DT SCE_NNP assay_NN is_VBZ therefore_RB
          biased_VBN towards_IN resolved_VBN or_CC more_RBR corrected_JJ metaphases_NNS and_CC
          it_PRP is_VBZ likely_JJ that_IN the_DT induced_VBN ΔH_NN 1_CD SCE_NNP frequency_NN is_VBZ
          actually_RB higher_RBR than_IN reported_VBD here_RB ._. The_DT SCE_NNP assay_NN was_VBD
          successful_JJ for_IN all_DT cell_NN lines_NNS indicating_VBG that_IN the_DT
          doubling_VBG times_NNS are_VBP close_RB to_TO 24_CD hours_NNS ._. This_DT indicates_VBZ that_IN
          the_DT overall_JJ cell_NN cycle_NN timing_NN is_VBZ similar_JJ in_IN all_DT of_IN the_DT
          cell_NN lines_NNS but_CC does_VBZ not_RB rule_VB out_RP variations_NNS in_IN
          stage-specific_JJ progression_NN ._.
        
        
          The_DT expression_NN of_IN the_DT C-_NNP terminal_NN mutations_NNS is_VBZ
          deleterious_JJ relative_NN to_TO the_DT N-_NNP terminal_NN mutations_NNS
          The_DT C-_NNP terminal_NN deletion_NN containing_VBG cell_NN lines_NNS have_VBP a_DT
          higher_JJR mean_NN chromosome_NN number_NN than_IN the_DT control_NN and_CC
          N-_NNP terminal_NN deletion_NN cell_NN lines_NNS ,_, except_IN for_IN the_DT ΔN_NN 1_CD cell_NN
          line_NN which_WDT is_VBZ somewhat_RB elevated_VBD (_( Table_NNP 3_LS )_) ._. This_DT increase_NN
          in_IN chromosome_NN number_NN suggests_VBZ that_IN the_DT C-_NNP terminal_NN
          mutations_NNS lead_VBP to_TO an_DT increase_NN in_IN the_DT aneuploidy_NN of_IN these_DT
          SV_NNP 40_CD -_: transformed_VBN cells_NNS by_IN inhibiting_VBG proper_JJ chromosome_NN
          separation_NN ._. The_DT increase_NN in_IN SCE_NNP frequency_NN correlates_NNS with_IN
          an_DT overall_JJ lower_JJR level_NN of_IN fusion_NN proteins_NNS in_IN the_DT
          C-_NNP terminal_NN mutation_NN cell_NN lines_NNS and_CC higher_JJR levels_NNS of_IN
          protein_NN expression_NN in_IN the_DT cell_NN lines_NNS with_IN N-_NNP terminal_NN
          deletions_NNS ._. These_DT data_NNS demonstrate_VBP that_DT mutation_NN of_IN the_DT
          helicase_NN and_CC C-_NNP terminal_NN domains_NNS of_IN BLM_NNP have_VBP a_DT greater_JJR
          effect_NN on_IN the_DT SCE_NNP frequency_NN than_IN does_VBZ mutation_NN of_IN the_DT
          N-_NNP terminal_NN domain_NN ._.
        
      
      
        Discussion_NNP
        
          The_DT Tet-on_NNP system_NN has_VBZ strengths_NNS and_CC
          weaknesses_NNS
          The_DT Tet_NNP inducible_JJ expression_NN system_NN has_VBZ experimental_JJ
          weaknesses_NNS in_IN that_IN the_DT activity_NN of_IN the_DT Tet-responsive_NNP
          activator_NN is_VBZ not_RB tightly_RB regulated_VBN and_CC some_DT cells_NNS do_VBP not_RB
          produce_VB inducible_JJ cell_NN lines_NNS ._. All_DT of_IN the_DT GFP-BLM_NNP fusion_NN
          proteins_NNS were_VBD produced_VBN at_IN a_DT low_JJ level_NN in_IN the_DT absence_NN of_IN
          inducer_NN ._. Cell_NNP lines_NNS with_IN a_DT favored_VBN reproductive_JJ potential_NN
          grew_VBD well_RB and_CC multiple_JJ useful_JJ stable_JJ transfectants_NNS were_VBD
          obtained_VBN (_( normal_JJ BLM_NNP and_CC N-_NNP terminal_NN deletion_NN genes_NNS )_) as_IN
          compared_VBN to_TO those_DT containing_VBG deleterious_JJ mutant_JJ alleles_NNS
          (_( helicase_NN and_CC C-_NNP terminal_NN deletions_NNS )_) ._. The_DT BS_NNP cell_NN line_NN
          used_VBN here_RB lacks_VBZ BLM_NNP [_NN 10_CD ]_NN and_CC all_DT cell_NN lines_NNS obtained_VBN
          from_IN transfection_NN of_IN the_DT normal_JJ GFP-BLM_NNP gene_NN had_VBD a_DT
          background_NN level_NN of_IN constitutive_JJ expression_NN leading_VBG to_TO a_DT
          partially_RB corrected_VBN SCE_NNP frequency_NN relative_JJ to_TO the_DT
          parental_JJ line_NN (_( 40_CD vs_NNS ._. 58_CD )_) [_NN 10_CD ]_NN ._. EGFP_NNP itself_PRP is_VBZ not_RB an_DT
          innocuous_JJ protein_NN ._. The_DT cell_NN lines_NNS expressing_VBG EGFP_NNP alone_RB
          grew_VBD the_DT most_RBS slowly_RB of_IN all_DT of_IN the_DT clones_NNS in_IN the_DT
          collection_NN and_CC had_VBD a_DT slightly_RB elevated_VBD SCE_NNP frequency_NN
          relative_JJ to_TO the_DT parental_JJ cell_NN line_NN (_( 65_CD -_: 70_CD vs_NNS ._. 58_CD
          exchanges_NNS )_) [_NN 10_CD ]_NN ._. When_WRB co-transfections_JJ were_VBD performed_VBN
          with_IN one_CD plasmid_NN containing_VBG the_DT Tet-responsive_NNP GFP-BLM_NNP
          gene_NN and_CC another_DT containing_VBG the_DT selection_NN unit_NN ,_, all_DT of_IN
          the_DT cell_NN lines_NNS tested_VBN had_VBD low_JJ SCEs_NNP without_IN induction_NN (_( 4_CD
          of_IN 4_LS )_) ._. Only_RB when_WRB both_DT the_DT GFP-BLM_NNP and_CC
          hygromycin-resistance_JJ expression_NN units_NNS were_VBD combined_VBN on_IN
          the_DT same_JJ plasmid_NN were_VBD useful_JJ inducible_JJ clones_NNS recovered_VBD ._.
          Despite_IN the_DT time_NN and_CC effort_NN required_VBN to_TO screen_VB multiple_JJ
          clones_NNS ,_, some_DT with_IN constitutive_JJ levels_NNS of_IN expression_NN ,_,
          experimentally_RB useful_JJ cell_NN lines_NNS were_VBD obtained_VBN that_WDT
          allowed_VBD investigation_NN of_IN the_DT function_NN of_IN the_DT N-_NNP terminus_JJ
          and_CC C-_NNP terminus_JJ of_IN BLM_NNP ._.
        
        
          The_DT Tet-inducible_NNP system_NN shows_VBZ better_JJR SCE_NNP
          correction_NN than_IN constitutive_JJ expression_NN
          Our_PRP$ previous_JJ study_NN used_VBD stable_JJ transfected_JJ cell_NN lines_NNS
          derived_VBN from_IN the_DT same_JJ SV_NNP 40_CD -_: transformed_VBN BS_NNP cell_NN line_NN used_VBN
          here_RB ,_, except_IN that_IN the_DT normal_JJ and_CC missense_NN alleles_NNS of_IN BLM_NNP
          were_VBD expressed_VBN from_IN a_DT constitutive_JJ promoter_NN [_NN 10_CD ]_NN ._. The_DT
          normal_JJ BLM_NNP cDNA_NN reduced_VBD the_DT SCE_NNP frequency_NN from_IN 58_CD to_TO 24_CD
          exchanges_NNS per_IN 46_CD chromosomes_NNS ._. This_DT is_VBZ partial_JJ correction_NN
          as_IN normal_JJ cell_NN lines_NNS have_VBP from_IN 4_CD -_: 10_CD exchanges_NNS per_IN 46_CD
          chromosomes_NNS [_NN 1_CD ]_NN ._. In_IN addition_NN the_DT cells_NNS expressing_VBG the_DT
          helicase-defective_JJ K_NNP 695_CD T_NN allele_NN grew_VBD slowly_RB and_CC
          eventually_RB died_VBD ._. These_DT results_NNS led_VBD us_PRP to_TO use_VB an_DT inducible_JJ
          expression_NN system_NN ._. In_IN this_DT study_NN the_DT SCE_NNP frequency_NN of_IN the_DT
          induced_VBN normal_JJ GFP-BLM_NNP cell_NN line_NN is_VBZ closer_JJR to_TO correction_NN
          (_( 12_CD exchanges_NNS )_) ._. The_DT K_NNP 695_CD T_NN protein_NN localizes_NNS in_IN a_DT pattern_NN
          similar_JJ to_TO the_DT normal_JJ protein_NN yet_RB increases_VBZ the_DT SCE_NNP
          frequency_NN ,_, suggesting_VBG that_IN the_DT dominant_JJ negative_JJ effect_NN
          of_IN this_DT allele_NN caused_VBD the_DT cell_NN lines_NNS made_VBN in_IN the_DT previous_JJ
          study_NN to_TO die_VB ._. Despite_IN the_DT limitations_NNS discussed_VBN above_IN ,_,
          the_DT Tet-on_NNP system_NN allowed_VBD isolation_NN of_IN inducible_JJ cell_NN
          lines_NNS which_WDT more_RBR accurately_RB paralleled_JJ normal_JJ than_IN did_VBD
          lines_NNS with_IN a_DT constitutive_JJ promoter_NN ,_, and_CC allowed_VBD the_DT
          isolation_NN and_CC evaluation_NN of_IN cell_NN lines_NNS expressing_VBG
          deleterious_JJ alleles_NNS ._.
        
        
          The_DT NBs_NNP appear_VBP to_TO be_VB regulatory_JJ depots_NNS for_IN
          BLM_NNP
          All_DT of_IN the_DT N-_NNP terminal_NN deletion_NN proteins_NNS are_VBP expressed_VBN
          at_IN a_DT stable_JJ level_NN near_IN normal_JJ ,_, reduce_VBP the_DT SCE_NNP frequency_NN
          to_TO near_IN normal_JJ ,_, and_CC are_VBP not_RB efficiently_RB packed_VBN in_IN the_DT
          NBs_NNP ._. Cells_NNP which_WDT lack_VBP PML_NNP do_VBP not_RB form_VB NBs_NNP and_CC have_VBP
          approximately_RB a_DT two-fold_JJ increase_NN in_IN SCE_NNP frequency_NN
          relative_JJ to_TO control_VB cells_NNS [_NN 29_CD ]_NN ._. This_DT is_VBZ similar_JJ to_TO the_DT
          SCE_NNP data_NN for_IN the_DT N-_NNP terminal_NN BLM_NNP deletions_NNS and_CC demonstrate_VB
          that_IN NB_NNP localization_NN is_VBZ not_RB a_DT requirement_NN for_IN BLM_NNP
          function_NN ._. NBs_NNP are_VBP likely_JJ to_TO be_VB storage_NN locations_NNS or_CC
          depots_NNS that_WDT regulate_VB the_DT release_NN or_CC recovery_NN of_IN BLM_NNP ._. All_DT
          of_IN the_DT N-_NNP terminal_NN deletion_NN proteins_NNS except_IN for_IN ΔN_NN 4_CD show_NN
          nucleolar_NN morphologies_NNS and_CC SCE_NNP frequencies_NNS close_RB to_TO
          normal_JJ ._. The_DT ΔN_NN 4_CD protein_NN has_VBZ a_DT lower_JJR correction_NN efficiency_NN
          and_CC a_DT different_JJ localization_NN pattern_NN than_IN the_DT other_JJ
          N-_NNP terminal_NN deletions_NNS ._. This_DT deletion_NN removes_VBZ a_DT cluster_NN of_IN
          acidic_JJ amino_JJ acids_NNS ,_, similar_JJ to_TO acidic_JJ activation_NN domains_NNS
          known_VBN to_TO activate_VBP transcription_NN in_IN a_DT variety_NN of_IN
          eucaryotes_NNS [_NN 36_CD ]_NN ._. Clusters_NNP of_IN acidic_JJ amino_JJ acids_NNS that_WDT
          function_NN as_IN transcriptional_NN activation_NN domains_NNS can_MD also_RB
          activate_VBP chromosomal_NN DNA_NNP replication_NN by_IN interacting_VBG with_IN
          replication_NN protein_NN A_DT (_( RPA_NNP )_) [_NN 37_CD ]_NN ._. BLM_NNP interacts_NNS with_IN
          RPA_NNP 70_CD in_IN vitro_NN [_NN 38_CD ]_NN and_CC associates_NNS with_IN RPA_NNP clusters_NNS in_IN
          cells_NNS [_NN 20_CD ]_NN ._. Other_JJ studies_NNS have_VBP demonstrated_VBN that_IN acidic_JJ
          activators_NNS can_MD relieve_VB nucleosomal_NN repression_NN and_CC that_IN
          the_DT anti-repression_JJ function_NN may_MD be_VB mediated_JJ by_IN chromatin_NN
          remodeling_VBG systems_NNS [_NN 39_CD ]_NN ._. Deletion_NNP of_IN this_DT acidic_JJ cluster_NN
          of_IN BLM_NNP has_VBZ an_DT effect_NN on_IN localization_NN and_CC SCE_NNP frequency_NN
          and_CC may_MD target_VB BLM_NNP to_TO RPA_NNP bound_VBN to_TO single-stranded_JJ DNA_NNP ,_,
          or_CC it_PRP may_MD allow_VB BLM_NNP to_TO function_VB with_IN chromatin_NN remodeling_VBG
          complexes_NNS at_IN sites_NNS of_IN ectopic_JJ invasion_NN events_NNS ._.
          The_DT N-_NNP terminal_NN deletions_NNS do_VBP not_RB efficiently_RB associate_JJ
          with_IN TOPIIIα_NNP by_IN immunofluorescent_NN examination_NN ._. This_DT does_VBZ
          not_RB rule_VB out_IN binding_JJ with_IN TOPIIIα_NNP in_IN the_DT more_RBR diffusely_RB
          stained_JJ regions_NNS ._. Studies_NNS in_IN 
          S_NNP ._. cerevisiae_NN suggest_VBP that_IN BLM_NNP and_CC
          TOPIIIα_NNP function_NN together_RB as_IN an_DT enzymatic_JJ complex_JJ [_NN 33_CD ,_,
          34_CD ]_NN ._. Alternatively_RB TOPIIIα_NNP could_MD regulate_VB BLM_NNP activity_NN by_IN
          altering_VBG its_PRP$ ability_NN to_TO bind_NN DNA_NNP substrates_NNS ._. In_IN vitro_NN
          binding_JJ studies_NNS [_NN 34_CD ]_NN identified_VBD two_CD regions_NNS of_IN BLM_NNP
          (_( amino_JJ acids_NNS 143_CD -_: 213_CD &_CC 1266_CD -_: 1417_CD ,_, Figure_NN 2_LS )_) that_DT
          interact_NN with_IN TOPIIIα_NNP ._. One_CD of_IN these_DT regions_NNS (_( 143_CD -_: 213_CD )_) is_VBZ
          removed_VBN by_IN the_DT ΔN_NN 2_CD construction_NN ._. The_DT cells_NNS express_VBP
          TOPIIIα_NNP in_IN multiple_NN sized_VBD spherical_JJ bodies_NNS but_CC no_DT
          co-localization_JJ with_IN the_DT GFP_NNP fusion_NN protein_NN is_VBZ evident_JJ
          (_( Figure_NN 4_CD F_NN )_) ._. It_PRP is_VBZ possible_JJ that_IN TOPIIIα_NNP binds_NNS BLM_NNP only_RB
          when_WRB BLM_NNP is_VBZ in_IN NBs_NNP or_CC that_IN the_DT C-_NNP terminal_NN BLM_NNP binding_JJ
          domain_NN is_VBZ of_IN low_JJ affinity_NN ._.
        
        
          The_DT nucleolus_JJ is_VBZ likely_JJ to_TO be_VB an_DT important_JJ site_NN for_IN
          BLM_NNP function_NN
          The_DT C-_NNP terminal_NN deletion_NN proteins_NNS do_VBP co-localize_JJ with_IN
          PML_NNP and_CC TOPIIIα_NNP in_IN the_DT NBs_NNP yet_RB elevate_NN the_DT SCE_NNP frequency_NN ._.
          The_DT helicase_NN and_CC C-_NNP terminal_NN mutations_NNS that_WDT fail_VBP to_TO
          localize_NN normally_RB in_IN the_DT nucleolus_JJ fail_VB to_TO reduce_VB the_DT
          SCEs_NNP and_CC implicate_VB the_DT nucleolus_JJ as_IN a_DT functional_JJ location_NN
          for_IN BLM_NNP during_IN DNA_NNP replication_NN ._. One_CD study_NN on_IN chromosome_NN
          abnormalities_NNS in_IN cells_NNS from_IN persons_NNS with_IN BS_NNP documented_VBN an_DT
          elevated_VBD frequency_NN of_IN recombination_NN events_NNS in_IN the_DT
          satellite_NN stalks_NNS of_IN acrocentric_JJ chromosomes_NNS [_NN 40_CD ]_NN ._. In_IN
          this_DT report_NN lymphocyte_NN chromosomes_NNS from_IN two_CD persons_NNS with_IN
          BS_NNP were_VBD compared_VBN to_TO those_DT from_IN unaffected_JJ persons_NNS ._. The_DT
          frequency_NN of_IN exchanges_NNS in_IN the_DT BS_NNP cells_NNS was_VBD estimated_VBN to_TO
          be_VB 6_CD /_NN 1000_CD and_CC less_JJR than_IN 0_CD ._. 1_CD /_NN 1000_CD in_IN control_NN cells_NNS ._. In_IN
          addition_NN the_DT cells_NNS from_IN one_CD of_IN the_DT persons_NNS with_IN BS_NNP had_VBD
          acrocentrics_NNS with_IN Q-_NNP bright_JJ satellites_NNS ._. The_DT lymphocytes_NNS
          from_IN this_DT individual_NN varied_VBD greatly_RB with_IN regard_NN to_TO the_DT
          number_NN of_IN Q-_NNP bright_JJ satellites_NNS and_CC which_WDT acrocentric_JJ
          chromosomes_NNS contained_VBD them_PRP ,_, documenting_VBG a_DT high_JJ frequency_NN
          of_IN recombination_NN in_IN the_DT rDNA_NN loci_NN of_IN BS_NNP cells_NNS ._. These_DT data_NNS
          are_VBP consistent_JJ with_IN a_DT model_NN in_IN which_WDT BLM_NNP functions_NNS to_TO
          untangle_NN invasive_JJ events_NNS in_IN multiple_JJ rDNA_NN loci_NN and_CC SCEs_NNP
          are_VBP used_VBN as_IN a_DT bypass_NN mechanism_NN when_WRB BLM_NNP is_VBZ absent_JJ ._.
        
        
          The_DT localization_NN of_IN BLM_NNP in_IN the_DT nucleolus_JJ is_VBZ not_RB an_DT
          artifact_NN but_CC rather_RB a_DT function_NN specified_VBN by_IN the_DT
          C-_NNP terminal_NN domain_NN
          The_DT precise_JJ function_NN of_IN the_DT C-_NNP terminus_JJ that_WDT directs_VBZ
          BLM_NNP to_TO the_DT nucleolus_JJ is_VBZ still_RB unclear_JJ ._. An_DT NMR_NNP structural_JJ
          analysis_NN of_IN the_DT HRD_NNP domain_NN of_IN Sgs_NNP 1_CD p_NN and_CC models_NNS for_IN the_DT
          WRN_NNP and_CC BLM_NNP domains_NNS suggests_VBZ that_IN this_DT region_NN is_VBZ a_DT
          single-strand_JJ nucleic_JJ acid_NN binding_JJ domain_NN that_IN functions_NNS
          as_IN an_DT accessory_JJ DNA_NNP binding_JJ region_NN with_IN the_DT helicase_NN
          domain_NN [_NN 41_CD ]_NN ._. Helicase_NNP motifs_NNS are_VBP conserved_JJ in_IN many_JJ
          proteins_NNS ._. The_DT specific_JJ function_NN of_IN individual_JJ helicases_NNS
          may_MD be_VB controlled_VBN by_IN a_DT substrate_NN selection_NN mechanism_NN in_IN
          the_DT accessory_JJ regions_NNS flanking_VBG the_DT helicase_NN domain_NN ._. The_DT
          C-_NNP terminus_JJ may_MD confer_VB on_IN BLM_NNP the_DT ability_NN to_TO recognize_VB and_CC
          bind_NN abnormal_JJ DNA_NNP structures_NNS such_JJ as_IN quadraplexes_NNS [_NN 17_CD ]_NN ._.
          Alternatively_RB the_DT flanking_VBG regions_NNS may_MD bind_NN to_TO
          recombination_NN proteins_NNS such_JJ as_IN RPA_NNP or_CC RAD_NNP 51_CD at_IN these_DT
          chromosomal_NN sites_NNS [_NN 38_CD ]_NN ._. The_DT dominant_JJ negative_JJ nature_NN of_IN
          the_DT C-_NNP terminal_NN deletions_NNS suggests_VBZ that_IN these_DT mutant_JJ
          proteins_NNS can_MD be_VB incorporated_VBN into_IN normal_JJ BLM-containing_NNP
          complexes_NNS and_CC inhibit_VB function_NN or_CC regulation_NN ._. The_DT
          numerous_JJ BLM_NNP bodies_NNS formed_VBN by_IN the_DT C-_NNP terminal_NN deletion_NN
          fusion_NN proteins_NNS may_MD sequester_VB repair_NN complexes_NNS that_IN BLM_NNP
          has_VBZ been_VBN shown_VBN to_TO associate_JJ with_IN [_NN 42_CD ]_NN ._.
          Many_JJ of_IN the_DT cell_NN lines_NNS showed_VBD modest_JJ levels_NNS of_IN
          over-expression_JJ of_IN the_DT fusion_NN proteins_NNS relative_JJ to_TO levels_NNS
          of_IN BLM_NNP found_VBD in_IN a_DT normal_JJ SV_NNP 40_CD -_: transformed_VBN cell_NN line_NN ._. The_DT
          immunofluorescent_NN images_NNS show_VBP an_DT apparent_JJ greater_JJR
          accumulation_NN of_IN fusion_NN protein_NN in_IN the_DT nucleolus_JJ than_IN is_VBZ
          found_VBN in_IN normal_JJ cells_NNS [_NN 20_CD ]_NN ._. The_DT stronger_JJR signals_NNS are_VBP
          caused_VBN by_IN the_DT expression_NN levels_NNS as_RB well_RB as_IN the_DT
          sensitivity_NN of_IN the_DT GFP_NNP reporter_NN gene_NN ._. When_WRB proteins_NNS are_VBP
          over-expressed_JJ they_PRP can_MD localize_NN non-specifically_JJ ._. The_DT
          advantage_NN of_IN the_DT system_NN here_RB is_VBZ that_IN the_DT parental_JJ cell_NN
          line_NN lacks_VBZ BLM_NNP and_CC therefore_RB the_DT fusion_NN protein_NN can_MD
          occupy_VB normal_JJ positions_NNS without_IN competing_VBG with_IN endogenous_JJ
          BLM_NNP ._. The_DT GFP-BLM_NNP fusion_NN protein_NN accumulates_NNS in_IN the_DT same_JJ
          nuclear_JJ structures_NNS as_IN determined_VBN previously_RB [_NN 20_CD ]_NN and_CC
          does_VBZ not_RB appear_VB to_TO cause_VB aberrant_NN structures_NNS at_IN the_DT
          levels_NNS expressed_VBD here_RB ._.
        
        
          BLM_NNP most_RBS likely_JJ functions_NNS in_IN recombinational_NN repair_NN
          during_IN DNA_NNP replication_NN
          The_DT DNA_NNP helicases_NNS of_IN the_DT RecQ_NNP family_NN are_VBP not_RB essential_JJ
          for_IN cellular_JJ viability_NN but_CC are_VBP important_JJ to_TO genomic_JJ
          stability_NN ._. Studies_NNS in_IN model_NN organisms_NNS suggest_VBP a_DT role_NN for_IN
          the_DT human_JJ orthologs_NNS in_IN recombinational_NN repair_NN during_IN DNA_NNP
          replication_NN ._. Experimental_NNP evidence_NN shows_VBZ that_IN RecQ_NNP and_CC
          nuclease_NN RecJ_NNP act_NN together_RB to_TO restart_VB stalled_VBN forks_NNS in_IN 
          E_NNP ._. coli_NNS [_NN 43_CD ]_NN ._. A_DT recent_JJ study_NN of_IN
          the_DT 
          S_NNP ._. cerevisiae_NN Sgs_NNP 1_CD p_NN gene_NN suggests_VBZ
          that_IN it_PRP removes_VBZ or_CC prevents_VBZ ectopic_JJ recombination_NN events_NNS
          between_IN non-homologous_JJ chromosomes_NNS [_NN 44_CD ]_NN ._. Experiments_NNS
          with_IN 
          X_NNP ._. laevis_NNS BLM_NNP demonstrates_VBZ its_PRP$
          requirement_NN in_IN a_DT reconstituted_JJ DNA_NNP replication_NN system_NN [_NN
          6_CD ]_NN ._. The_DT in_IN vitro_NN enzymatic_JJ activities_NNS documented_VBN for_IN BLM_NNP ,_,
          unwinding_VBG G_NNP 4_CD quadraplexes_NNS ,_, holliday_NN junctions_NNS and_CC D-_NNP loops_NNS
          [_NN 17_CD ,_, 18_CD ,_, 19_CD ]_NN ,_, as_RB well_RB as_IN the_DT phenotypes_NNS of_IN BS_NNP cells_NNS [_NN 1_CD ]_NN
          are_VBP consistent_JJ with_IN both_DT of_IN these_DT models_NNS ._. BLM_NNP has_VBZ been_VBN
          localized_VBN to_TO two_CD GC-rich_NNP repeated_VBD regions_NNS (_( nucleolus_JJ and_CC
          telomeres_NNS )_) [_NN 20_CD ]_NN where_WRB the_DT replication_NN machinery_NN is_VBZ
          likely_JJ to_TO need_VB assistance_NN to_TO back_VB up_RP in_IN order_NN to_TO untangle_NN
          stalled_VBD forks_NNS and_CC resolve_VB inappropriate_JJ invasive_JJ events_NNS
          between_IN repeated_VBN sequence_NN elements_NNS found_VBD on_IN multiple_JJ
          chromosomes_NNS ._. BLM_NNP has_VBZ been_VBN found_VBN in_IN large_JJ protein_NN complex_JJ
          with_IN BRCA_NNP 1_CD and_CC multiple_JJ DNA_NNP repair_NN and_CC replication_NN
          factors_NNS [_NN 42_CD ]_NN that_WDT may_MD recognize_VB and_CC repair_VB abnormal_JJ DNA_NNP
          structures_NNS that_WDT occur_VBP during_IN DNA_NNP replication_NN ._. As_IN both_DT the_DT
          helicase_NN activity_NN and_CC the_DT C-_NNP terminus_JJ of_IN BLM_NNP are_VBP required_VBN
          to_TO maintain_VB genomic_JJ stability_NN it_PRP is_VBZ likely_JJ that_IN the_DT
          C-_NNP terminus_JJ of_IN BLM_NNP recognizes_VBZ abnormal_JJ DNA_NNP structures_NNS and_CC
          the_DT helicase_NN activity_NN unwinds_NNS these_DT multi-stranded_JJ
          structures_NNS to_TO engender_NN efficient_JJ repair_NN ._.
        
      
      
        Conclusions_NNP
        The_DT GFP-BLM_NNP fusion_NN protein_NN has_VBZ helicase_NN activity_NN in_IN
        vitro_NN and_CC functions_NNS to_TO reduce_VB the_DT SCE_NNP frequency_NN in_IN BS_NNP
        cells_NNS ._. Deletions_NNP of_IN BLM_NNP expressed_VBD as_IN GFP_NNP fusion_NN proteins_NNS
        demonstrate_VBP that_IN the_DT N-_NNP terminal_NN domain_NN directs_VBZ BLM_NNP into_IN
        nuclear_JJ bodies_NNS and_CC the_DT C-_NNP terminal_NN domain_NN is_VBZ necessary_JJ for_IN
        efficient_JJ nucleolar_NN localization_NN ._. The_DT stable_JJ nucleolar_NN
        localization_NN of_IN BLM_NNP is_VBZ not_RB due_JJ to_TO over-expression_JJ but_CC
        rather_RB to_TO a_DT function_NN encoded_JJ in_IN the_DT C-_NNP terminus_JJ of_IN BLM_NNP ._.
        Mutations_NNP in_IN the_DT helicase_NN domain_NN and_CC deletions_NNS in_IN the_DT
        C-_NNP terminal_NN domain_NN have_VBP a_DT dominant_JJ negative_JJ effect_NN on_IN the_DT
        SCE_NNP frequency_NN and_CC cause_VB an_DT increase_NN in_IN chromosome_NN
        abnormalities_NNS ,_, whereas_IN N-_NNP terminal_NN deletions_NNS have_VBP relatively_RB
        little_JJ effect_NN ._. These_DT data_NNS demonstrate_VBP that_IN the_DT helicase_NN
        activity_NN and_CC C-_NNP terminal_NN domain_NN directed_VBD nucleolar_NN
        localization_NN of_IN BLM_NNP is_VBZ essential_JJ to_TO maintain_VB genomic_JJ
        stability_NN ._. The_DT NBs_NNP appear_VBP to_TO be_VB storage_NN or_CC regulatory_JJ sites_NNS
        for_IN BLM_NNP and_CC are_VBP not_RB required_VBN for_IN BLM_NNP activity_NN ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Expression_NNP and_CC purification_NN of_IN GFP-BLM_NNP
          The_DT normal_JJ BLM_NNP cDNA_NN (_( B_NNP 3_LS )_) [_NN 3_CD ]_NN was_VBD fused_JJ to_TO the_DT C_NNP
          terminus_JJ of_IN EGFP_NNP (_( Clontech_NNP )_) ._. An_DT 8_CD x_SYM polyhistidine_NN epitope_NN
          tag_NN was_VBD added_VBN to_TO the_DT N-_NNP terminus_JJ of_IN EGFP_NNP with_IN an_DT
          oligonucleotide_NN adapter_NN
          (_( 5_CD '_POS AAAACTGCAGCGGCCGCCACCATGCACCAC-CACCACACCACCACCACGTGAGCAAGGGCGAGGAGCTGTTCACCG_NNP 3_CD '_POS )_) ._.
          DNA_NNP sequencing_VBG confirmed_VBN the_DT construction_NN ._. A_DT recombinant_JJ
          baculovirus_JJ expressing_VBG the_DT fusion_NN gene_NN behind_IN the_DT
          polyhedrin_NN promoter_NN was_VBD made_VBN in_IN Sf_NNP 9_CD cells_NNS using_VBG
          Invitrogen_NNP 's_POS BlueBac_NNP kit_NN according_VBG to_TO the_DT supplier_NN 's_POS
          protocol_NN ._. Sf_NNP 9_CD cells_NNS were_VBD infected_JJ for_IN 72_CD hours_NNS at_IN a_DT
          multiplicity_NN of_IN infection_NN (_( MOI_NNP )_) of_IN 1_CD and_CC sorted_VBN for_IN green_JJ
          cells_NNS by_IN FACS_NNP analysis_NN (_( MoFlo_NNP ,_, Cytomation_NNP )_) at_IN one_CD and_CC ten_CD
          cells_NNS per_IN well_RB into_IN 96_CD well_RB microtiter_NN plates_NNS containing_VBG
          uninfected_JJ Sf_NNP 9_CD cells_NNS [_NN 29_CD ]_NN ._. These_DT primary_JJ viral_JJ stocks_NNS
          were_VBD assayed_JJ and_CC amplified_VBN by_IN infecting_VBG Sf_NNP 9_CD cells_NNS in_IN 24_CD
          well_RB plates_NNS ._. The_DT secondary_JJ stocks_NNS were_VBD analyzed_VBN by_IN PCR_NNP
          and_CC screened_VBD for_IN a_DT nuclear-localized_JJ GFP_NNP signal_NN [_NN 30_CD ]_NN ._.
          Viral_NNP stocks_NNS containing_VBG only_RB the_DT recombinant_JJ GFP-BLM_NNP
          construction_NN were_VBD amplified_VBN to_TO produce_VB high_JJ titer_NN stocks_NNS
          for_IN expression_NN ._. Maximal_NNP expression_NN of_IN GFP-BLM_NNP was_VBD found_VBN
          to_TO be_VB 72_CD hours_NNS of_IN infection_NN by_IN western_JJ analysis_NN with_IN
          α-_NN BLM_NNP [_NN 10_CD ]_NN ._. Sf_NNP 9_CD cells_NNS in_IN Sf_NNP 900_CD -_: II_NNP medium_NN (_( Invitrogen_NNP )_)
          were_VBD infected_JJ at_IN a_DT MOI_NNP of_IN 5_CD -_: 10_CD and_CC harvested_VBN after_IN 72_CD
          hours_NNS ._. Efficiency_NNP of_IN infection_NN was_VBD monitored_VBN by_IN
          immunofluorescent_NN microscopy_NN (_( Figure_NN 1_CD A_DT )_) ._. The_DT cell_NN
          pellets_NNS were_VBD stored_VBN at_IN -_: 70_CD °_NN C_NNP ._.
          Cell_NNP lysis_NNS was_VBD monitored_VBN by_IN fluorescent_NN microscopy_NN and_CC
          aliquots_NNS of_IN column_NN fractions_NNS were_VBD assayed_JJ in_IN the_DT wells_NNS of_IN
          96_CD well_RB microtiter_NN plates_NNS for_IN green_JJ fluorescence_NN using_VBG a_DT
          Molecular_NNP Dynamics_NNP Storm_NN Phosphorlmager_NNP ._. The_DT frozen_VBN cell_NN
          pellets_NNS from_IN 500_CD ml_NN spinner_NN flask_NN culture_NN were_VBD lysed_JJ by_IN
          sonication_NN in_IN Buffer_NNP A_DT (_( 50_CD mM_NN Tris-_NNP HCL_NNP pH_NN 8_CD ,_, 5_CD mM_NN
          β-mercaptoethanol_JJ ,_, 1_CD mM_NN EDTA_NNP ,_, 1_CD μg_NN /_NN ml_NN leupeptin_NN ,_,
          pepstatin_NN ,_, and_CC E_NNP 64_CD ,_, and_CC 1_CD mM_NN PMSF_NNP )_) containing_VBG 450_CD mM_NN NaCL_NNP
          and_CC 1_CD %_NN NP_NNP 40_CD ._. The_DT crude_NN lysate_NN was_VBD diluted_VBN 1_CD :_: 3_CD with_IN Buffer_NNP
          A_DT ._. After_IN centrifugation_NN (_( 15_CD min_NN at_IN 20_CD ,_, 000_CD ×_NN g_SYM at_IN 4_CD °_NN C_NNP )_) the_DT
          soluble_JJ material_NN was_VBD loaded_VBN onto_IN a_DT BioRad_NNP Macroprep_NNP High_NNP
          Q_NNP column_NN (_( 2_CD ._. 5_LS cm_NN ×_NN 20_CD cm_NN )_) equilibrated_JJ with_IN Buffer_NNP A_DT +_NN
          150_CD mM_NN NaCl_NNP ._. The_DT column_NN was_VBD washed_VBN with_IN 5_CD column_NN volumes_NNS
          of_IN Buffer_NNP A_DT +_NN 150_CD mM_NN NaCl_NNP and_CC 5_CD column_NN volumes_NNS of_IN Buffer_NNP
          A_DT +_NN 250_CD mM_NN NaCl_NNP (_( no_DT EDTA_NNP )_) ._. GFP-BLM_NNP was_VBD eluted_JJ with_IN Buffer_NNP
          B_NNP (_( Buffer_NNP A_DT +_NN 500_CD mM_NN NaCl_NNP and_CC no_DT EDTA_NNP )_) ._. Pooled_NNP Macroprep_NNP
          Q_NNP fractions_NNS containing_VBG GFP-BLM_NNP were_VBD loaded_VBN onto_IN a_DT 5_CD ml_NN
          HiTrap_NNP metal_NN chelate_NN column_NN (_( Amersham_NNP Pharmacia_NNP )_) charged_VBN
          with_IN 
          NiS_NNP 0_CD 4_CD equilibrated_JJ in_IN Buffer_NNP B_NNP ._. The_DT
          metal_NN chelate_NN resin_NN was_VBD washed_VBN with_IN successive_JJ 10_CD column_NN
          volumes_NNS of_IN Buffer_NNP B_NNP +_NN 10_CD mm_NN imidazole_NN ,_, Buffer_NNP B_NNP +_NN 50_CD mM_NN
          imidazole_NN ,_, and_CC Buffer_NNP B_NNP +_NN l_NN 00_CD mM_NN imidazole_NN ._. Highly_NNP
          purified_JJ GFP-BLM_NNP eluted_JJ in_IN Buffer_NNP B_NNP +_NN 200_CD mM_NN imidazole_NN
          and_CC was_VBD stored_VBN at_IN -_: 70_CD °_NN C_NNP ._. Assays_NNP for_IN DNA-dependent_NNP ATPase_NNP
          and_CC oligonucleotide_NN unwinding_VBG were_VBD performed_VBN as_IN before_IN [_NN
          10_CD ]_NN ._.
        
        
          Construction_NNP of_IN inducible_JJ cell_NN lines_NNS expressing_VBG
          GFP-BLM_NNP and_CC mutant_JJ alleles_NNS
          The_DT SV_NNP 40_CD -_: transformed_VBN BS_NNP cell_NN line_NN GM_NNP 0855_CD B_NNP (_( blm_NN
          Ash_NNP [_NN 2281_CD Δ_NN 6_CD ins_NNS 7_CD ]_NN /_NN bim_NN Ash_NNP [_NN 2281_CD Δ_NN 6_CD ins_NNS 7_CD ]_NN )_) [_NN 3_CD ]_NN was_VBD
          transfected_JJ with_IN a_DT plasmid_NN expressing_VBG the_DT tetracycline_NN or_CC
          doxycycline_NN (_( Tet_NNP )_) -_: responsive_JJ transcriptional_NN
          transactivator_NN from_IN a_DT CMV_NNP promoter_NN [_NN 32_CD ]_NN ._. G_NNP 418_CD -_: resistant_JJ
          cell_NN lines_NNS were_VBD selected_VBN in_IN DMEM_NNP +_NN 10_CD %_NN fetal_JJ bovine_JJ serum_NN
          (_( Clontech_NNP ,_, Tet-free_NNP )_) +_NN 200_CD μg_NN /_NN ml_NN Geneticin_NNP (_( Invitrogen_NNP )_) ._.
          Seventeen_CD G_NNP 418_CD -_: resistant_JJ clones_NNS were_VBD screened_VBD for_IN
          transfection_NN efficiency_NN and_CC Tet-responsiveness_NNP ._. The_DT
          efficiency_NN was_VBD measured_VBN by_IN transient_JJ transfection_NN of_IN a_DT
          CMV_NNP promoter-driven_JJ GFP_NNP gene_NN (_( pEGFP-Cl_JJ ,_, Clontech_NNP )_) and_CC
          responsiveness_NNS by_IN transfection_NN of_IN a_DT Tet-regulated_NNP GFP_NNP
          gene_NN (_( pBi_NN EGFP_NNP ,_, Clontech_NNP )_) ._. One_CD cell_NN line_NN (_( HG_NNP 2551_CD a_DT )_) had_VBD an_DT
          8_CD %_NN transfection_NN efficiency_NN (_( constitutive_JJ GFP_NNP )_) and_CC 0_CD ._. 25_CD %_NN
          green_JJ cells_NNS without_IN Tet_NNP and_CC 3_CD ._. 8_CD %_NN with_IN 1_CD μg_NN /_NN ml_NN Tet_NNP (_( 15_CD
          fold_VB induction_NN and_CC 45_CD %_NN inducible_JJ transfection_NN efficiency_NN
          vs_NNS ._. constitutive_JJ )_) ,_, and_CC was_VBD chosen_VBN for_IN transfection_NN of_IN
          GFP-BLM_NNP alleles_NNS ._.
          The_DT BLM_NNP alleles_NNS used_VBN here_RB were_VBD cloned_VBN as_IN fusions_NNS with_IN
          the_DT C-_NNP terminus_JJ of_IN EGFP_NNP (_( Clontech_NNP )_) ._. The_DT K_NNP 695_CD T_NN missense_NN
          allele_NN was_VBD described_VBN before_IN [_NN 10_CD ]_NN ._. The_DT deletion_NN alleles_NNS
          of_IN BLM_NNP were_VBD constructed_VBN using_VBG digestion_NN with_IN two_CD
          restriction_NN enzymes_NNS and_CC insertion_NN of_IN an_DT oligonucleotide_NN
          adapter_NN ._. The_DT sites_NNS and_CC the_DT sequences_NNS of_IN the_DT adapters_NNS
          were_VBD :_:
          ΔN_NN 1_CD (_( EcoRI-SmaI_NNP ,_,
          5_CD '_POS AATCTGCAGCTATGAAATCCC_NNP 3_CD '_POS /_NN 5_CD '_POS GACGTCGATACTTTAGGG_NNP 3_CD '_POS )_) ,_,
          ΔN_NN 2_CD (_( SmaI-ClaI_NNP ,_,
          5_CD '_POS GGGATACTGCTATTTGCAT_NNP 3_CD '_POS /_NN 5_CD '_POS CCCTATGACGATAAACGTAGC_NNP 3_CD '_POS )_) ,_,
          ΔN_NN 3_CD (_( ClaI-AvrII_NNP ,_,
          5_CD '_POS CGATGATCTGACTACCACCC_NNP 3_CD '_POS /_NN 5_CD '_POS TACTAGACTGATGGGTGGGATC_NNP 3_CD '_POS )_) ,_,
          ΔN_NN 4_CD (_( XmnI-AhdI_NNP ,_,
          5_CD '_POS GCTTTCCTCAGCCAAGACAGA_NNP 3_CD '_POS /_NN 5_CD '_POS CGAAAGGAGTCGGTTCTGTC_NNP 3_CD '_POS )_) ,_,
          ΔH_NN 1_CD (_( NcoI-SalI_NNP ,_,
          5_CD '_POS CATGAATCTGGCTG_NNP 3_CD '_POS /_NN 5_CD '_POS TTAGACCGACAGCT_NNP 3_CD '_POS )_) ,_,
          ΔC_NN 1_CD (_( SalI-PvuI_NNP ,_,
          5_CD '_POS TCGACATTGACCAGGCGAT_NNP 3_CD '_POS /_NN 5_CD '_POS GTAACTGGTCCGC_NNP 3_CD '_POS )_) and_CC ΔC_NN 2_CD
          (_( PvuI-EcoNI_NNP ,_, 5_CD '_POS CGCTAATGAAAGGAAGAGGAAAAAGATGCCAGCCTCC_NNP
          3_CD '_POS /_NN 5_CD '_POS TAGCGATTACTTTCCTTCTCCTTTTTCTACGGT_NNP 3_CD '_POS )_) ._.
          The_DT ΔC_NN 2_CD construction_NN restores_NNS the_DT nuclear_JJ localization_NN
          signal_NN [_NN 30_CD ]_NN ._. Oligonucleotides_NNP were_VBD made_VBN by_IN Invitrogen_NNP ._.
          The_DT deletion_NN junctions_NNS were_VBD confirmed_VBN by_IN DNA_NNP
          sequencing_VBG ._.
          Cell_NNP line_NN HG_NNP 2551_CD a_DT was_VBD transfected_JJ [_NN 10_CD ]_NN with_IN normal_JJ
          and_CC mutant_JJ GFP-BLM_NNP genes_NNS cloned_VBN behind_IN the_DT Tet-responsive_NNP
          promoter_NN in_IN plasmid_NN pTRE_NN (_( Clontech_NNP )_) ._. Stable_NNP transfected_JJ
          cell_NN lines_NNS containing_VBG these_DT constructions_NNS were_VBD selected_VBN
          by_IN two_CD methods_NNS :_: co-transfection_JJ of_IN these_DT plasmids_NNS with_IN a_DT
          second_JJ plasmid_NN containing_VBG a_DT hygromycin-resistance_JJ gene_NN
          driven_VBN by_IN a_DT Herpes_NNP simplex_NN thymidine_NN kinase_NN promoter_NN or_CC
          transfection_NN of_IN GFP-BLM_NNP allele_NN plasmids_NNS that_WDT had_VBD been_VBN
          modified_VBN to_TO contain_VB the_DT hygromycin-resistance_JJ gene_NN
          expression_NN unit_NN ._. Few_JJ useful_JJ cell_NN lines_NNS were_VBD obtained_VBN from_IN
          the_DT first_JJ method_NN ._. Most_JJS transfected_JJ clones_NNS that_WDT were_VBD
          resistant_JJ to_TO 200_CD μg_NN /_NN ml_NN G_NNP 418_CD and_CC 200_CD μg_NN /_NN ml_NN hygromycin_NN did_VBD
          not_RB produce_VB GFP_NNP upon_IN induction_NN ._. In_IN contrast_NN transfection_NN
          with_IN the_DT modified_VBN vector_NN where_WRB the_DT two_CD expression_NN units_NNS
          are_VBP on_IN the_DT same_JJ plasmid_NN produced_VBD many_JJ useful_JJ cell_NN lines_NNS ._.
          The_DT ΔC_NN 2_CD cell_NN line_NN was_VBD from_IN the_DT first_JJ transfection_NN method_NN
          and_CC all_DT of_IN the_DT others_NNS were_VBD selected_VBN using_VBG the_DT second_NN ._.
        
        
          Immunoflourescent_NNP and_CC western_JJ analysis_NN of_IN cell_NN
          lines_NNS
          Cells_NNP were_VBD plated_JJ onto_IN glass_NN coverslips_NNS in_IN 6_CD well_RB
          tissue_NN culture_NN plates_NNS in_IN selective_JJ medium_NN ,_, induced_VBD the_DT
          next_JJ day_NN with_IN 1_CD μg_NN /_NN ml_NN Tet_NNP and_CC fixed_VBN with_IN 2_CD %_NN
          paraformaldehyde_NN 24_CD hours_NNS later_RB ._. Immunofluorescent_NNP
          staining_VBG and_CC microscopy_NN was_VBD as_IN performed_VBN previously_RB [_NN
          20_CD ]_NN ._. Antibody_NNP against_IN human_JJ Topoisomerase_NNP IIIα_NNP was_VBD
          provided_VBN by_IN F_NN ._. B_NNP ._. Johnson_NNP and_CC L_NNP ._. Guarente_NNP [_NN 33_CD ]_NN ._. Antibody_NNP
          against_IN BLM_NNP was_VBD described_VBN before_IN [_NN 10_CD ]_NN ._. Antibody_NNP against_IN
          GFP_NNP was_VBD from_IN Roche_NNP Molecular_NNP Biochemicals_NNP ._. Western_JJ
          transfers_NNS were_VBD as_IN before_IN [_NN 10_CD ]_NN ._. ECF_NNP and_CC ECL_NNP reagents_NNS were_VBD
          purchased_VBN from_IN Amersham_NNP /_NN Pharmacia_NNP and_CC used_VBN according_VBG to_TO
          the_DT supplier_NN 's_POS instructions_NNS ._. SDS_NNP 4_CD -_: 12_CD %_NN polyacrylamide_NN
          gels_NNS and_CC Precision_NNP protein_NN molecular_JJ weight_NN markers_NNS were_VBD
          from_IN BioRad_NNP ._.
        
        
          Sister_NNP Chromatid_NNP Exchange_NNP Assay_NNP
          Fibroblast_NNP cell_NN cultures_NNS were_VBD divided_VBN into_IN two_CD T-_NNP 25_CD
          tissue_NN culture_NN flasks_NNS and_CC one_CD was_VBD induced_VBN with_IN 1_CD μg_NN /_NN ml_NN
          Tet_NNP the_DT next_JJ day_NN ._. After_IN a_DT 24_CD hour_NN period_NN of_IN induction_NN 20_CD
          μM_NN BrdU_NNP was_VBD added_VBN to_TO both_DT flasks_NNS ._. Labeling_VBG ,_, colcemid_NN
          treatment_NN and_CC harvest_NN were_VBD as_IN before_IN [_NN 10_CD ]_NN ._. Fixed_NNP
          preparations_NNS were_VBD dropped_VBN onto_IN clean_VB glass_NN slides_NNS and_CC
          stained_JJ with_IN 0_CD ._. 1_CD mg_NN /_NN ml_NN acridine_NN orange_NN for_IN 5_CD minutes_NNS ,_,
          followed_VBN by_IN a_DT wash_NN in_IN running_VBG water_NN for_IN 2_CD minutes_NNS and_CC a_DT 1_CD
          minute_NN incubation_NN in_IN Sorensen_NNP 's_POS buffer_NN (_( 67_CD mM_NN KH_NNP 
          2_CD PO_NNP 
          4_CD +_NN 67_CD mM_NN Na_NNP 
          2_CD HPO_NNP 
          4_LS )_) ._. The_DT wet_JJ slides_NNS were_VBD covered_VBN with_IN
          glass_NN coverslips_NNS and_CC metaphases_NNS photographed_VBN immediately_RB
          with_IN a_DT Zeiss_NNP Axioskop_NNP fluorescence_NN microscope_NN using_VBG the_DT
          FITC_NNP filter_NN and_CC a_DT 100_CD ×_NN objective_NN ._. Images_NNP were_VBD captured_VBN
          with_IN a_DT CCD_NNP camera_NN (_( Kodak_NNP Micromax_NNP 1400_CD )_) connected_VBN to_TO an_DT
          Apple_NNP Power_NNP Mac_NNP 9600_CD ._.
        
      
    
  
